Introduction Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), has demonstrated remarkable effectiveness in reducing blood glucose levels, promoting weight loss, and improving cardiovascular outcomes in patients with type 2 diabetes. Recent reports, however, draw attention to the development of uncommon but severe adverse effects
6301 Reached25 Comments6 Likes
Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure
150 Reached
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Pancytopenia, a rare presentation of hyperthyroidism
832 Reached2 Comments
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes